Related Experiment Video
Updated: Jul 1, 2026
08:46
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Published on: March 7, 2017
Palliative care in pediatrics
1Palliative Care, Children's Hospital of Wisconsin, Milwaukee, WI 53201, USA. bhimelstein@chw.org
Anesthesiology Clinics of North America
|November 29, 2005
Summary
Pediatric palliative care focuses on enhancing life quality and restoring wholeness for children with serious illnesses. It supports families in living fully, rather than solely focusing on end-of-life care.
Area of Science:
- Pediatrics
- Palliative Care Medicine
- Family Medicine
Background:
- Pediatric palliative care is often misunderstood as solely end-of-life care.
- Children with life-threatening conditions and their families face unique challenges.
- There is a need for comprehensive care models that address the holistic needs of these children.
Purpose of the Study:
- To redefine pediatric palliative care as a holistic approach to improving quality of life.
- To present the fundamental principles of family-centered pediatric palliative care.
- To discuss the application of these principles in clinical practice.
Main Methods:
- Literature review on pediatric palliative care principles.
- Synthesis of existing research and clinical guidelines.
- Conceptual framework development for family-centered care.
Main Results:
- Pediatric palliative care emphasizes living fully, not just dying.
- Key principles include family-centeredness, symptom management, and psychosocial support.
- Restoring wholeness and improving quality of life are central goals.
Conclusions:
- Family-centered pediatric palliative care is essential for children with complex conditions.
- This approach enhances the well-being of both the child and the family.
- Effective implementation requires understanding and applying core principles to alleviate suffering and promote optimal living.
Related Concept Videos
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...